Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunoprecise Antibodies Ltd
(NQ:
IPA
)
0.3760
+0.0276 (+7.92%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunoprecise Antibodies Ltd
< Previous
1
2
3
4
5
6
7
Next >
BioStrand® Unveils a Revolutionary Approach to Biological Sequence Retrieval: A Fusion of Natural Language Processing and Database Research
November 13, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
EXCLUSIVE: Antibody-Discovery Platform Provider ImmunoPrecise's Subsidiary Highlights Approach to Biological Sequence Retrieval
November 13, 2023
ImmunoPrecise Antibodies Ltd's (NASDAQ: IPA) subsidiary BioStrand has published a preprint of its white paper titled "New Paradigm for Biological Sequence Retrieval Inspired by Natural
Via
Benzinga
IPA’s Subsidiary, BioStrand, Provides an Update on LENSai™
October 25, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
Earnings Outlook For ImmunoPrecise Antibodies
September 13, 2023
Via
Benzinga
ImmunoPrecise Antibodies's Earnings Outlook
July 06, 2023
Via
Benzinga
IPA Provides Update on Growth Strategy and Recent Share Price Movement
October 23, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
Overcoming the Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological Data
October 20, 2023
Via
ACCESSWIRE
Overcoming The Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological Data
October 19, 2023
Biotechnology research involves a vast amount of complex information that spans different dimensions, such as the functions of proteins, the 3D structures of molecules and the genetic information...
Via
Benzinga
How ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody Research
October 13, 2023
Via
ACCESSWIRE
How ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody Research
October 12, 2023
The introduction of artificial intelligence (AI) in healthcare has revolutionized the field, allowing for a more personalized approach to patient care. AI algorithms have the ability to process and...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
ImmunoPrecise Antibodies Announces CFO Transition
September 19, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024
September 14, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024 on September 14, 2023
September 08, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
IPA Announces Board Refreshment
September 05, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
IPA Responds to 13D Filing
August 09, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Antibodies Invites Investors and Stakeholders to Exclusive Interview with Market Radius Research
July 14, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2023
July 07, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
Earnings Scheduled For July 7, 2023
July 07, 2023
Companies Reporting Before The Bell • ImmunoPrecise Antibodies (NASDAQ:IPA) is expected to report quarterly loss at $0.13 per share on revenue of $4.31 million.
Via
Benzinga
Costco, AZZ And 3 Stocks To Watch Heading Into Friday
July 07, 2023
With U.S. stock futures trading slightly lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Investor Sentiment Drops Following Economic Reports
July 07, 2023
The CNN Money Fear and Greed index showed some a decline in overall sentiment among U.S. investors on Thursday. The Dow Jones dropped more than 300 points on Thursday as investors assessed the recent...
Via
Benzinga
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2023 on July 7th, 2023.
June 29, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
“Convergence of AI and Biology: Companies at the Forefront of Transformative Innovations”:- IPA, MRKR, PRAX , RMED
June 21, 2023
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
IPA’s Subsidiary BioStrand Unveils Use Case for Solving the Information Integration Dilemma (IID)
June 13, 2023
From
ImmunoPrecise Antibodies
Via
Business Wire
Healthcare and AI “Paradigm Shift” Stocks in Focus: IPA, MGRX, INBS, RMED
June 09, 2023
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) Is Strategically Built To Advance The Future
June 09, 2023
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
IPA Releases New HYFT-Powered In Silico Humanization Platform, Aims to Disrupt the Transgenic Animal Model Market
June 06, 2023
From
ImmunoPrecise Antibodies
Via
Business Wire
IPA's Subsidiary, BioStrand, Solves the Information Integration Dilemma (IID) for Systems Biology
May 30, 2023
From
ImmunoPrecise Antibodies
Via
Business Wire
IPA to Present at Jefferies Healthcare Conference 2023
May 17, 2023
From
ImmunoPrecise Antibodies
Via
Business Wire
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 15, 2023
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Via
Benzinga
The Street Reports: NASDAQ Stocks Poised to Disrupt the Markets: IPA, RELI, SKYX, AZ
May 03, 2023
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.